Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 433 (TSXV: $KHRN.V)
(TSX: $VIVO.TO) (OTC: $BBRW) (CSE: $IMCC.C)
Delta, Kelowna, BC, June 24, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/06241KHRN-VIVO-BBRW-IMCC.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
Khiron Life Sciences Corp. (TSXV:
KHRN) (OTCQX:
KHRNF) announced the
completed installation of a state-of-the-art 2,600 panel solar park that will
generate electricity to power the Company's production facility in Doima,
Colombia.
Developed
with ReFeel, a leading Italian renewable Company with more than 80 MW installed
in Europe and Latin America, Khiron's solar park is expected to generate up to
700 kWh through a photovoltaic (PV) system that comprises 2,618 installed solar
panels. With the construction of the PV system, Khiron can self-generate up to
40% of the energy it needs for day-to-day facility operations and is expected
to reduce CO2 emissions by 570 tons a year.
"Installation
of the solar park at our Doima production facility brings Khiron exponential
efficiencies, allowing us to significantly reduce operational energy costs and
benefit from tax reductions, as we actively commit to deploying sustainability
initiatives across our operations," comments Khiron CEO and Director
Alvaro Torres. "We're proud to take actions aimed at sharply reducing
greenhouse gas emissions and making this contribution to help counter the
global environmental challenge."
The
solar park project delivered direct employment to a team of 20 personnel in the
local Doima community and provided access to globally recognized solar energy
technical training in PV systems and renewable energy installations, enhancing
the teams future participation in projects of the same type, at a regional and
national level. "We are continuing to support the Doima community,
improving resource and waste management in the area as part of our company-wide
sustainability program," continues, Mr. Torres.
VIVO
Cannabis Inc. (TSX:
VIVO) (OTCQX:
VVCIF) and its subsidiaries have
entered into both a product supply agreement and a clinic
services agreement with Medical Cannabis by Shoppers™.
Under the terms of the supply
agreement, the Company's licensed producers will offer a broad portfolio of
Canna Farms™ and Beacon Medical™ branded medical cannabis products through the
Medical Cannabis by Shoppers™ online sales platform, including its latest 2.0
offerings such as chocolates and extracts. VIVO-branded products will be
accessible to Medical Cannabis by Shoppers™ patients across Canada.
"We have a six-year track
record of cultivating and producing high-quality, medical-grade cannabis and
are thrilled to partner with Shoppers Drug Mart Inc." said Barry Fishman,
CEO of VIVO. "VIVO is extremely committed to the medical cannabis market.
We are pleased to be able to leverage the insights learned from over 100,000
patient visits to our Harvest Medicine clinics and telemedicine platform. As we
continue to invest in product development to expand our medical cannabis
product line and satisfy unmet patient needs, we are excited by the prospect of
introducing our novel future offerings to Medical Cannabis by Shoppers™
patients."
Under the terms of the clinic
services agreement, the Company's subsidiary, Harvest Medicine, will provide
cannabis education services to patients who are appropriate candidates for
cannabinoid-based products available from Medical Cannabis by Shoppers™ and
provide consulting services to its Cannabis Care team.
"As a leading clinic network dedicated
to advancing medical cannabis patient outcomes through quality education, the
team of health care practitioners at Harvest Medicine look forward to
developing a collaborative interdisciplinary approach to medical cannabis care
with Medical Cannabis by Shoppers™," commented Carole Chan, President of
Harvest Medicine.
BrewBilt
Manufacturing Inc. (OTC:
BBRW) announced that
the Beer-Industry giants are turning to CANNA-BEER processing in an effort to
boost sales. As the laws continue to evolve, canna-beer, as part of the larger
cannabis-infused beverage category, presents unique opportunities for seasoned
and new users alike. More than just another way to get high, THC-infused beers
offers a consistent, predictable, and responsible way to engage with cannabis.
CEO Jef Lewis stated, “We just
received $1,050,000 in new orders, brewery and cannabis, in the past 48 hours.
Statistical trends for 2020 indicated that quality was the most important
factor when choosing an alcohol brand, so while consumers may not be drinking
as frequently, when they do drink, they’re opting for quality over quantity or
mindful drinking. 58% of Beer-Industry insiders state that quality beer and
equipment is the new trend for 2020. BrewBilt has the highest reputation for
quality equipment for cannabis and brewery systems. The future of our revenue
model is based upon “ghost-breweries” where there is a huge demand for contract
brewing and packaging, 68% of activity on the platform this year has come from
people looking for contract brewing capacity. The white label market was valued
at $100B in 2020 across all sectors. 32% of tender requests on the platform are
for white label.”
Lewis further stated, “The future of
BrewBilt is vibrant and aggressive as we meet quality demands in our
industries. This means stabilization and a re-energized core of more successful
breweries. Additionally, as we’ve already seen, the rise of cannabis and
sobriety will play a role on the further impact of the beer category. The
continued maturation of the category is going to force owners and leadership to
get more organized, prepared, and professional. BrewBilt is on that forefront
as growing demand for beers that are high in flavor and food compatibility, but
lower in calories: fruit-infused sour beers and low-cal IPAs are two categories
we believe will grow strong for many years to come. Our customers have come to
trust our manufacturing processes and quality, and are going to continue
demanding the latest new products. Their taste profiles will evolve over the
next decade and we’ll see companies in our space evolve with our customers. For
BrewBilt the next 10 years should be about making sure beer is America’s
beverage of choice.”
IM
Cannabis Corp. (CSE:IMCC), one
of the world's pioneering medical cannabis companies with operations in Israel
and across Europe, announced
today that a recent peer-reviewed study conducted by
Professor Dedi Meiri at the Technion – Israeli Institute of Technology
("Technion") investigating the associations between phytocannabinoid
treatment and migraine frequency, found that medical cannabis results in
long-term reduction of migraine frequency in over 60% of treated patients1. The
study also found that medical cannabis is associated with less disability and
lower antimigraine medication intake. Furthermore, Technion's research indicated
that two strains used in the study (IMC's London and Tel-Aviv strains) were
found to be specifically effective.
"At IMC, we have high
conviction that the development of evidence-based research in medical cannabis
will lead to a new generation of medical products to treat a variety of
indications and illnesses over the long-term. We will continue to partner with
visionaries and leading researchers such as Professor Dedi Meiri and Technion
to advance research and development of medical cannabis as it aligns strongly
with our vision of leadership in global medical cannabis," said Oren
Shuster, CEO of IMC. "The results of this study follow our announcement
last week of a binding term sheet with MGC Pharmaceuticals Ltd. to distribute
CannEpil® in Israel for the treatment of refractory epilepsy. As we continue to
develop relationships with innovators in research and development, we plan to
use our global distribution network to bring a range of high-quality medical
cannabis products to patients across the world."
Professor Dedi Meiri, commented,
"In the past five years, my lab, together with the main growers in Israel,
have been running the Israeli database project. As part of this project, we
have been testing the associations between phytocannabinoid treatment and
migraine frequency. In this work we observed that 89% of the respondents
reported lower current migraine disability and lower negative impact, and lower
rates of opioid and triptan consumption. Moreover, we were able to demonstrate
that the respondents consumed cannabis strains with higher doses of the
phytocannabinoid ms_373_15c and lower doses of the phytocannabinoid ms_331_18d.
Two of the most impactful strains in the study were IMC branded strains,
Tel-Aviv and London."
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and
equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
